Darunavir (Prezista, TMC114): Research
- Resistance to Darunavir Falling Since Approval of the Protease Inhibitor in 2006 (March 11, 2013)
From National AIDS Treatment Advocacy Project
- Darunavir/Ritonavir and Etravirine as a Prevention Method Is Biologically Plausible (Summer 2012)
To read PDF, click here.
In Being Alive Newsletter, from Being Alive
On TheBodyPRO.com
- Darunavir Use During Pregnancy (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
 Top 10 HIV/AIDS-Related Clinical Developments of 2011 (December 1, 2011)
David Alain Wohl, M.D., on HIV treatment as prevention; the dawning of pre-exposure prophylaxis (PrEP), but with women absent; the concept of "viremia copy-years"; the impact of race and gender on HIV treatment outcomes; setbacks for two treatment approaches involving Isentress; new hepatitis C therapies; a new once-daily HIV pill; the rising rates of HIV among black MSM; and what comes after "test and treat."
From TheBody.com
- Pharmacokinetics of Darunavir and Fosamprenavir in Pregnancy (July/August 2011)
To read PDF, click here.
- Another NRTI-Sparing Regimen Does Well in Treatment-Naive Patients (July 25, 2011)
From aidsmap.com
- Novel Mutations and Shifting Susceptibility to Darunavir and Tipranavir (September 15, 2010)
From National AIDS Treatment Advocacy Project
- Metabolic Marker Changes Similar After 12 Weeks of Darunavir and Atazanavir (July 26, 2010)
From National AIDS Treatment Advocacy Project
- Lessons From GRACE: A U.S. Study Focused on Women Living With HIV (June 2010)
From The Well Project
- Odin -- Darunavir-Ritonavir Once or Twice Daily (March/April 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- Monotherapy With Darunavir-Ritonavir -- the Monet Study (March/April 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- Surprising Changes in Body Fat With Darunavir Monotherapy (March/April 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- Once-Daily Darunavir in Treatment-Experienced Patients (March 8, 2010)
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Once-Daily Darunavir Effective and Less Toxic Than Twice-Daily in Experienced Patients Without Prior Darunavir Resistance: ODIN (February 18, 2010)
From aidsmap.com
- Prezista Monotherapy May Prove Effective (February 1, 2010)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Boosted Darunavir Monotherapy Works Well in Two Studies (July 23, 2009)
Ritonavir-boosted darunavir alone maintains HIV suppression in most patients who achieved an undetectable viral load on combination antiretroviral therapy, according to two studies.
From aidsmap.com
- Darunavir Superior to Lopinavir in 48-Week Study in Treatment-Experienced Patients (July 6, 2007)
From aidsmap.com
- Adding Etravirine to Prezista Improves Anti-HIV Activity, Studies Show (July 6, 2007)
From aidsmap.com
- GRACE Under Pressure (December 2006)
To read PDF, click here.
In TAGline, from Treatment Action Group
- 48-Week TMC114 + Ritonavir Data Set New Bar for Efficacy in Triple-Class-Experienced Patients (August 15, 2006)
In XVI International AIDS Conference
On TheBodyPRO.com
- TMC114 Significantly Outperforms Control Protease Inhibitors in Triple-Class-Experienced Patients, Even in Absence of Enfuvirtide (July 27, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
On TheBodyPRO.com
|
Advertisement
|
Email
Glossary
